这项技术为难治性精神疾病的治疗打开了突破口，目前该技术已延伸至难治性强迫症、抽动障碍等疾病治疗。 近日，上海交通大学附属瑞金医院分享了一名病史长达16年的抑郁症患者在接受了脑深部电刺激（DBS）结合脑机接口（BCI）技术的创新疗法后走出抑郁 的病例。 孙伯民表示，这项技术为难治性精神疾病的治疗打开了突破口，目前该技术已延伸至难治性强迫症、抽动障碍等疾病治疗。"与电休克可能造成的记忆损伤 不同，它通过微创植入实现长期调控。"他解释称，"而对比需要终身服药的传统方案，则避免了肝肾损伤等副作用。" 孙伯民同时指出，DBS联合BCI技术也并非适用于所有的抑郁症患者，但可以为走投无路的难治性抑郁症患者提供一种全新、微创的干预可能。他表示，目 前这种新疗法临床已经治疗了30多例。"现在病人分流比较厉害，有无创神经调控治疗，如经颅磁刺激，经颅电刺激等，还有聚焦超声的磁波刀等。"孙伯民 说道。他还强调，抑郁症是一种复杂的疾病，早期识别和规范治疗至关重要。 抑郁症正在成为现代社会重要的精神疾病，而且年轻化趋势严重，抑郁症患者年龄越来越小。据中国科学院最新研究发现，中国的抑郁症患者规模近一人， 18岁以下的抑郁症患者占总人数的3 ...

Brainsway Ltd. Sponsored ADR (BWAY) shares rallied 5.3% in the last trading session to close at $11.49. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 1.7% gain over the past four weeks. The sharp upsurge in BWAY shares can be attributed to positive market sentiment surrounding the recent clinical trial results for BrainsWay's accelerated Deep TMS therapy in treating Major Depressive Disorder (MDD). The mult ...

Supernus Pharmaceuticals (SUPN) M&A Announcement June 16, 2025 08:30 AM ET Speaker0 Good morning, everyone, and welcome to Sperna's Business Update Conference Call. At this time, all participants are in a listen only mode. Later, we will conduct a question and answer session. Instructions will follow at that time. As a reminder, this conference call is being recorded. I would now like to turn the conference over to Peter Bassa, Investor Relations representative for Abertis Pharmaceuticals. You may begin. Sp ...

Sage Therapeutics (SAGE) M&A Announcement June 16, 2025 08:30 AM ET Speaker0 Good morning, everyone, and welcome to Sperna's Business Update Conference Call. At this time, all participants are in a listen only mode. Later, we will conduct a question and answer session. Instructions will follow at that time. As a reminder, this conference call is being recorded. I would now like to turn the conference over to Peter Bassa, Investor Relations representative for Abertis Pharmaceuticals. You may begin. Speaker1 ...